BridgeBio Pharma, Inc. SC 13D and SC 13D/A reports

Location
3160 Porter Dr., Suite 250, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/13/2024, 03:27 PM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report Nov 6, 2024
SC 13D/A Report SC 13D/A Sep 17, 2024
SC 13D/A Report SC 13D/A Aug 20, 2024
SC 13D/A Report SC 13D/A Nov 22, 2023
SC 13D/A Report SC 13D/A Jul 20, 2023
SC 13D/A Report SC 13D/A Feb 17, 2021
SC 13D/A Report SC 13D/A #1 Jan 26, 2021
SC 13D/A Report SC 13D/A Jan 26, 2021
SC 13D Report SC 13D Oct 15, 2020
SC 13D/A Report SC 13D/A Oct 6, 2020
SC 13D/A Report SC 13D/A Oct 5, 2020
SC 13D/A Report SC 13D/A Jun 1, 2020
SC 13D/A Report SC 13D/A Oct 15, 2019
SC 13D/A Report SC 13D/A Aug 8, 2019
SC 13D Report SC 13D Jul 10, 2019
SC 13D/A Report SC 13D/A Jul 9, 2019
SC 13D Report Jul 8, 2019
SC 13D/A Report SC 13D/A May 30, 2019
SC 13D/A Report SC 13D/A Dec 13, 2018
SC 13D/A Report SC 13D/A Dec 11, 2018
SC 13D/A Report SC 13D/A Dec 7, 2018
SC 13D Report SC 13D Aug 1, 2018